COVID - 19 and Advanced Gastro-intestinal Cancer Treatment

NCT04686747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-01-03

No results posted yet for this study

Summary

A multicenter Italian retrospective study on COVID-19 pandemic condition and advanced Gastro - Intestinal Cancer.

Are in Italy increased the new diagnosis of GI cancer in advanced stage in the 2020 compared with 2019, as a consequence of COVID-19?

Conditions

Sponsors & Collaborators

  • S.M. Misericordia Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-03-01
Completion
2021-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04686747 on ClinicalTrials.gov